Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Galphimia glauca as per indication in centesimal
potencies (CH): It is planned as administering Galphimia glauca as per indication in centesimal potencies (CH). Each dose will consist
dosage and repetition
depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the
globules or from eating, drinking, smoking or brushing teeth withi
dosage and repetition will be maintained depending upon the individual requirement of the cases.
All sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm.
Total dura
Sponsors
Jawaharlal Nehru Homoeopathic Medical College Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient suffering from Allergic rhinitis (ICD 11 CA08.0Z) for at least 1 year. 2. Age 18 to 65 years. 3. Patients of either sex or transgender 4. Literate patients; ability to read and write in Gujarati, Hindi or English and willingness to give informed consent voluntarily and to comply with the study procedure
Exclusion criteria
Exclusion criteria: 1. Patient who are too sick for consultation 2. Having complications of bacterial/viral infection of upper respiratory tract 3. Vulnerable population – unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 4. Patients with risk of developing bronchial asthma 5. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life 6. Pregnant and puerperal women, and lactating mothers 7. Substance abuse and/or dependence 8. Self-reported immune-compromised state 9. Not having any previous history of allergic attack of symptoms of AR 10. Patients who have taken any homoeopathic medicines in last 3 months and under any other medications for allergic rhinitis 11. Simultaneous participation in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mini- Rhino-Conjunctivitis Quality of Life Questionnaire (Mini-RQLQ)Timepoint: At baseline and every month up to 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| SF-12Timepoint: At baseline and every month up to 2 months;Total serum IgE level and absolute eosinophil count (AEC)Timepoint: Baseline and after 2 months | — |
Countries
India
Contacts
Public ContactDr Indrani Halder
Jawaharlal Nehru Homoeopathic Medical college, Parul University
Outcome results
None listed